Log In

PDS Biotechnology Corporation (PDSB)

Versamune-based COVID-19 Vaccine Consortium Received Brazilian Government Grant

March 11, 2021
Report ID: 12122
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ā€˜Get Reportā€™ button to login and view the research report.

Not a Member? Click ā€˜Joinā€™ or ā€˜Get Reportā€™ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

ā€Œ
PDS Biotechnology Corporation
PDS Biotechnology Corporation
Healthcare
Biotechnology
Ticker
PDSB
Current Price
$5.21 -1.7%
Market Cap
$160.8M
Price Target
Refer to Report
Volume
358.7K
52wk Range
$2.89 - $13.65
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
8/15/2023
ā€Œ
2Q23 Achieves Important Milestones With More To Follow
2Q23 Achieves Important Milestones With More To Follow (PDSB)
4 min read
7/18/2023
ā€Œ
New PDS0301 Combination Data To Be Presented
New PDS0301 Combination Data To Be Presented (PDSB)
5 min read
6/16/2023
ā€Œ
Answering Questions About The VERSATILE-002 Data
Answering Questions About The VERSATILE-002 Data (PDSB)
6 min read
6/15/2023
ā€Œ
Reiterating Outperform ā€“ Phase 2 Trial Meets Efficacy Endpoint
Reiterating Outperform ā€“ Phase 2 Trial Meets Efficacy Endpoint (PDSB)
4 min read

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
Ā© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In